OOIR: Observatory of International Research

Papers

(The H4-Index of European Respiratory Review is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Sex and gender in asthma	181
The impact of outdoor air pollution on COVID-19: a review of evidence fromin vitro, animal, and human studies	161
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management	145
Post-acute COVID-19 syndrome	140
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea	99
COVID-19 pneumonia: pathophysiology and management	97
Clinical significance and applications of oscillometry	89
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes	72
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	72
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	72
Bidirectional relationships of comorbidity with obstructive sleep apnoea	72
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	64
Asthma and COVID-19: an update	63
Diagnosis, course and management of hypersensitivity pneumonitis	58
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	57
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	57
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	56
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	55
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	55
Chronic cough: new insights and future prospects	54
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	52
Lung cancer is also a hereditary disease	50
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	46
Sex and gender in pulmonary arterial hypertension	46
Just breathe: a review of sex and gender in chronic lung disease	45

Lung transplantation for interstitial lung disease	45
Update on biology and management of mesothelioma	44
Recent developments in the treatment of small cell lung cancer	43
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	43
Pulmonary hypertension phenotypes in patients with systemic sclerosis	42
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women	42
Eosinophils and eosinophilic immune dysfunction in health and disease	41
Management of tracheo-oesophageal fistula in adults	41
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	40
Systematic review and meta-analysis of residential radon and lung cancer in never-smokers	39
Current evidence for COVID-19 therapies: a systematic literature review	38
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis	38
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	37
Sex and gender in respiratory physiology	37
Influenza vaccination: protecting the most vulnerable	37